What is the recommended administration and dosing of Straterra (atomoxetine) for a patient with Attention Deficit Hyperactivity Disorder (ADHD)?

Strattera (Atomoxetine) Administration and Dosing for ADHD

Atomoxetine should be initiated at 40 mg daily for patients over 70 kg and adults, or 0.5 mg/kg daily for children and adolescents up to 70 kg, then titrated every 7-14 days to a target dose of 80 mg daily (or 1.2 mg/kg) with a maximum of 100 mg daily (or 1.4 mg/kg, whichever is lower). 1, 2

Initial Dosing Strategy

For adults and patients over 70 kg:

• Start at 40 mg orally daily 3, 1
• This can be administered as a single morning dose or split into two evenly divided doses (morning and evening) to reduce side effects 2, 4, 5

For children and adolescents up to 70 kg:

• Start at 0.5 mg/kg daily 2, 1
• Use weight-based sequential titration 2

Titration Schedule

• Increase dose every 7-14 days 3, 2
• Target dose: 80 mg daily for adults (or 1.2 mg/kg for pediatric patients) 3, 2, 1
• Maximum dose: 100 mg daily or 1.4 mg/kg daily, whichever is lower 3, 2, 1

Critical timing consideration: Atomoxetine has a delayed onset of therapeutic effect requiring 6-12 weeks for full benefit, unlike stimulants which work within days 2, 6. Patients must take it consistently every day to maintain steady-state norepinephrine reuptake blockade in the prefrontal cortex 2.

Dosing Adjustments Required

For CYP2D6 poor metabolizers or patients taking strong CYP2D6 inhibitors (e.g., paroxetine, fluoxetine):

• These patients have 10-fold higher drug exposure with a half-life of approximately 24 hours 2, 7
• Dose adjustment downward is necessary 1
• Approximately 7% of Caucasians and 2% of African Americans are poor metabolizers 2

For hepatic impairment:

• Dose reduction required due to increased atomoxetine exposure 1, 7

Administration Flexibility

• Can be given as a single daily dose (morning or evening) 2, 4, 5
• Can be split into two evenly divided doses to minimize side effects like initial somnolence or gastrointestinal symptoms 2, 4, 5
• Single morning dosing provides "around-the-clock" symptom coverage extending into evening and next morning 2, 7, 8

Common Pitfalls to Avoid

Do not increase dosage too rapidly: This increases risk of somnolence, gastrointestinal symptoms, and decreased appetite 2. Stick to the 7-14 day titration intervals 3, 2.

Do not expect immediate results: Unlike stimulants, full therapeutic effects take 6-12 weeks to develop 2. Assess response only after this timeframe has elapsed 2.

Do not discontinue prematurely: The medication requires consistent daily administration to maintain therapeutic norepinephrine levels 2.

Critical Safety Monitoring

Black Box Warning: Monitor closely for suicidal ideation in children and adolescents, especially during the first few months of treatment or with dose changes 2, 1, 7.

Cardiovascular monitoring:

• Check blood pressure and heart rate at baseline and regularly during treatment 2, 6
• Modest increases in heart rate and blood pressure occur but are generally well tolerated 4, 5

Growth monitoring in pediatric patients:

• Track height and weight regularly 2, 1
• Initial loss in expected height and weight may occur but typically returns to normal long-term 7

Positioning in Treatment Algorithm

Atomoxetine is FDA-approved as first-line therapy but functions as second-line in clinical practice due to smaller effect sizes compared to stimulants 2. Consider atomoxetine as first-line specifically for:

• Patients with comorbid substance use disorders (not a controlled substance with negligible abuse potential) 2, 4, 5, 9
• Patients with tic disorders or Tourette's syndrome 2
• Patients experiencing sleep disturbances on stimulants 2
• Patients with comorbid anxiety (atomoxetine does not exacerbate anxiety like stimulants can) 2, 7, 9